Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer

References

• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500; PMID:20559327; http://dx.doi.org/10.1038/nri2785
   PubMed Web of Science ®Google Scholar
• Savage PA, Malchow S, Leventhal DS. Basic principles of tumor-associated regulatory T cell biology. Trends Immunol 2013; 34:33-40; PMID:22999714; http://dx.doi.org/10.1016/j.it.2012.08.005
   PubMed Web of Science ®Google Scholar
• Martin F, Ladoire S, Mignot G, Apetoh L, Ghiringhelli F. Human FOXP3 and cancer. Oncogene 2010; 29:4121-9; PMID:20498631; http://dx.doi.org/10.1038/onc.2010.174
   PubMed Web of Science ®Google Scholar
• Yaqub S, Aandahl EM. Inflammation Versus Adaptive Immunity in Cancer Pathogenesis. Crit Rev Oncog 2009; 15:43-63; PMID:20136627; http://dx.doi.org/10.1615/CritRevOncog.v15.i1-2.20
   PubMedGoogle Scholar
• deLeeuw RJ, Kost SE, Kakal JA, Nelson BH. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 2012; 18:3022-9; PMID:22510350; http://dx.doi.org/10.1158/1078-0432.CCR-11-3216
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30; PMID:23335087; http://dx.doi.org/10.3322/caac.21166
   PubMed Web of Science ®Google Scholar
• Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244:10-5; PMID:16794383; http://dx.doi.org/10.1097/01.sla.0000217673.04165.ea
   PubMed Web of Science ®Google Scholar
• Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 2008; 8:170; PMID:18547417; http://dx.doi.org/10.1186/1471-2407-8-170
   PubMed Web of Science ®Google Scholar
• Sandhu V, Bowitz Lothe IM, Labori KJ, Lingjaerde OC, Buanes T, Dalsgaard AM, Skrede ML, Hamfjord J, Haaland T, Eide TJ et al. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas. Mol Oncol 2015; 9:758-71; PMID:25579086; http://dx.doi.org/10.1016/j.molonc.2014.12.002
   PubMed Web of Science ®Google Scholar
• Evans A, Costello E. The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol 2012; 3:270; PMID:22969725; http://dx.doi.org/10.3389/fphys.2012.00270
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu X, Guo S, Zhang C, Tang Y, Tian Y, Ni B, Lu B, Wang H. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. PLoS One 2014; 9:e91551; PMID:24637664; http://dx.doi.org/10.1371/journal.pone.0091551
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yanagimoto H, Satoi S, Toyokawa H, Hirooka S, Yamaki S, Yui R, Yamao J, Kim S, Kwon AH. Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer. Pancreas 2012; 41:409-15; PMID:22158072; http://dx.doi.org/10.1097/MPA.0b013e3182373a66
   PubMed Web of Science ®Google Scholar
• Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006; 12:5423-34; PMID:17000676; http://dx.doi.org/10.1158/1078-0432.CCR-06-0369
   PubMed Web of Science ®Google Scholar
• McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H et al. Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia. Cancer Cell 2014; 25:621-37; PMID:24823639; http://dx.doi.org/10.1016/j.ccr.2014.03.014
   PubMed Web of Science ®Google Scholar
• Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM et al. Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer. Sci Transl Med 2012; 4:164ra59; http://dx.doi.org/10.1126/scitranslmed.3004566; PMID:23241743
   Web of Science ®Google Scholar
• Yang S, Wang B, Guan C, Wu B, Cai C, Wang M, Zhang B, Liu T, Yang P. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol 2011; 89:85-91; PMID:20952660; http://dx.doi.org/10.1189/jlb.0910506
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, Greenson J, Chang A, Rolinski J et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J Immunol 2011; 186:4388-95; PMID:21357259; http://dx.doi.org/10.4049/jimmunol.1003251
   PubMed Web of Science ®Google Scholar
• Wang K, Kim Min K, Di Caro G, Wong J, Shalapour S, Wan J, Zhang W, Zhong Z, Sanchez-Lopez E, Wu L-W et al. Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis. Immunity; 41:1052-63; PMID:25526314; http://dx.doi.org/10.1016/j.immuni.2014.11.009
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203:1701-11; PMID:16818678; http://dx.doi.org/10.1084/jem.20060772
   PubMed Web of Science ®Google Scholar
• Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106:4793-8; PMID:19273860; http://dx.doi.org/10.1073/pnas.0900408106
   PubMed Web of Science ®Google Scholar
• Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, Valmori D. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 2009; 106:8635-40; PMID:19439651; http://dx.doi.org/10.1073/pnas.0900621106
   PubMed Web of Science ®Google Scholar
• Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-9; PMID:19171879; http://dx.doi.org/10.1182/blood-2008-10-183251
   PubMed Web of Science ®Google Scholar
• Vizio B, Novarino A, Giacobino A, Cristiano C, Prati A, Ciuffreda L, Montrucchio G, Bellone G. Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome. Exp Ther Med 2012; 4:70-8; PMID:23060925; http://dx.doi.org/10.3892/etm.2012.553
   PubMed Web of Science ®Google Scholar
• Zhou L, Lopes JE, Chong MM, Ivanov, II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY et al. TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453:236-40; PMID:18368049; http://dx.doi.org/10.1038/nature06878
   PubMed Web of Science ®Google Scholar
• Du R, Zhao H, Yan F, Li H. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells. J Leukoc Biol 2014; 96:39-48; PMID:24744433; http://dx.doi.org/10.1189/jlb.1RU0114-010RR
   PubMed Web of Science ®Google Scholar
• Chen X, Oppenheim JJ. Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol 2011; 11:1489-96; PMID:21635972; http://dx.doi.org/10.1016/j.intimp.2011.05.018
   PubMed Web of Science ®Google Scholar
• Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205:1903-16; PMID:18663128; http://dx.doi.org/10.1084/jem.20080397
   PubMed Web of Science ®Google Scholar
• Bayer AL, Yu A, Malek TR. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 2007; 178:4062-71; PMID:17371960; http://dx.doi.org/10.4049/jimmunol.178.7.4062
   PubMed Web of Science ®Google Scholar
• Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26:371-81; PMID:17363300; http://dx.doi.org/10.1016/j.immuni.2007.02.009
   PubMed Web of Science ®Google Scholar
• Huber S, Gagliani N, Esplugues E, O'Connor W, Jr., Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011; 34:554-65; PMID:21511184; http://dx.doi.org/10.1016/j.immuni.2011.01.020
   PubMed Web of Science ®Google Scholar
• Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Bruning JC, Muller W et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34:566-78; PMID:21511185; http://dx.doi.org/10.1016/j.immuni.2011.03.018
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1004; PMID:10510089; http://dx.doi.org/10.1084/jem.190.7.995
   PubMed Web of Science ®Google Scholar
• Wormann SM, Diakopoulos KN, Lesina M, Algul H. The immune network in pancreatic cancer development and progression. Oncogene 2014; 33:2956-67; PMID:23851493; http://dx.doi.org/10.1038/onc.2013.257
   Google Scholar
• Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 2013; 25:305-12; PMID:24211039; http://dx.doi.org/10.1016/j.smim.2013.10.009
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-89; PMID:16473830; http://dx.doi.org/10.1016/j.immuni.2006.01.001
   PubMed Web of Science ®Google Scholar
• Xu L, Kitani A, Fuss I, Strober W. Cutting edge: Regulatory T cells induce CD4+CD25 -Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol 2007; 178:6725-9; PMID:17513718; http://dx.doi.org/10.4049/jimmunol.178.11.6725
   PubMed Web of Science ®Google Scholar
• Pandiyan P, Conti Heather R, Zheng L, Peterson Alanna C, Mathern Douglas R, Hernández-Santos N, Edgerton M, Gaffen Sarah L, Lenardo Michael J. CD4+CD25+Foxp3+ Regulatory T Cells Promote Th17 Cells In Vitro and Enhance Host Resistance in Mouse Candida albicans Th17 Cell Infection Model. Immunity 2011; 34:422-34; PMID:21435589; http://dx.doi.org/10.1016/j.immuni.2011.03.002
   PubMed Web of Science ®Google Scholar
• Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, Pedotti R, Pucillo CE, Colombo MP. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009; 114:2639-48; PMID:19643985; http://dx.doi.org/10.1182/blood-2009-05-220004
   PubMed Web of Science ®Google Scholar
• Blatner NR, Bonertz A, Beckhove P, Cheon EC, Krantz SB, Strouch M, Weitz J, Koch M, Halverson AL, Bentrem DJ et al. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci U S A 2010; 107:6430-5; PMID:20308560; http://dx.doi.org/10.1073/pnas.0913683107
   PubMed Web of Science ®Google Scholar
• Huh JR, Leung MW, Huang P, Ryan DA, Krout MR, Malapaka RR, Chow J, Manel N, Ciofani M, Kim SV et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 2011; 472:486-90; PMID:21441909; http://dx.doi.org/10.1038/nature09978
   PubMed Web of Science ®Google Scholar
• Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA et al. SPectrum of cancer risk among us solid organ transplant recipients. JAMA 2011; 306:1891-901; PMID:22045767; http://dx.doi.org/10.1001/jama.2011.1592
   PubMed Web of Science ®Google Scholar
• Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009; 6:699-708; PMID:19806144; http://dx.doi.org/10.1038/nrgastro.2009.177
   PubMed Web of Science ®Google Scholar
• Chang SH, Mirabolfathinejad SG, Katta H, Cumpian AM, Gong L, Caetano MS, Moghaddam SJ, Dong C. T helper 17 cells play a critical pathogenic role in lung cancer. Proc Natl Acad Sci U S A 2014; 111:5664-9; PMID:24706787; http://dx.doi.org/10.1073/pnas.1319051111
   PubMed Web of Science ®Google Scholar
• Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011; 25:1271-7; PMID:21369705; http://dx.doi.org/10.3892/or.2010.1118
   PubMed Web of Science ®Google Scholar
• Du J, Huang C, Zhou B, Ziegler SF. Isoform-specific inhibition of ROR α-mediated transcriptional activation by human FOXP3. J Immunol 2008; 180:4785-92; PMID:18354202; http://dx.doi.org/10.4049/jimmunol.180.7.4785
   PubMed Web of Science ®Google Scholar
• Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, Riethmacher D, Si-Tahar M, Di Santo JP, Eberl G. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 2008; 205:1381-93; PMID:18504307; http://dx.doi.org/10.1084/jem.20080034
   PubMed Web of Science ®Google Scholar
• Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, Dankof A, Krenn V, Schon MP, Scheffold A, Lowe JB et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 2005; 106:3097-104; PMID:16014565; http://dx.doi.org/10.1182/blood-2005-05-1864
   PubMed Web of Science ®Google Scholar
• Gallo E, Katzman S, Villarino AV. IL-13-producing Th1 and Th17 cells characterize adaptive responses to both self and foreign antigens. Eur J Immunol 2012; 42:2322-8; PMID:22684943; http://dx.doi.org/10.1002/eji.201142227
   PubMed Web of Science ®Google Scholar
• Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, Querci V, Angeli R, Matucci A, Fambrini M et al. Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125:222-30.e4; PMID:20109749; http://dx.doi.org/10.1016/j.jaci.2009.10.012
   PubMed Web of Science ®Google Scholar
• Wang Y-H, Voo KS, Liu B, Chen C-Y, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu Y-J. A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207:2479-91; PMID:20921287; http://dx.doi.org/10.1084/jem.20101376
   PubMed Web of Science ®Google Scholar
• Chen X, Oppenheim JJ. Th17 cells and Tregs: unlikely allies. J Leukoc Biol 2014; 95:723-31; PMID:24563509; http://dx.doi.org/10.1189/jlb.1213633
   PubMed Web of Science ®Google Scholar
• Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29:771-81; PMID:18993084; http://dx.doi.org/10.1016/j.immuni.2008.08.018
   PubMed Web of Science ®Google Scholar
• Ganeshan K, Bryce PJ. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. J Immunol 2012; 188:594-603; PMID:22156492; http://dx.doi.org/10.4049/jimmunol.1102389
   PubMed Web of Science ®Google Scholar
• Kuehn HS, Radinger M, Gilfillan AM. Measuring Mast Cell Mediator Release. Curr Protoc Immunol. 2010; Chapter 7:Unit7.38; PMID:21053305; http://dx.doi.org/10.1002/0471142735.im0738s91
   Google Scholar